Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy
|
|
- Emily McDonald
- 6 years ago
- Views:
Transcription
1 Journal of Neuro-Oncology 44: , Kluwer Academic Publishers. Printed in the Netherlands. Clinical Study Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy Yuta Shibamoto 1, Keisuke Sasai 2, Masaki Kokubo 2 and Masahiro Hiraoka 2 1 Department of Oncology, Institute for Frontier Medical Sciences; 2 Department of Radiology, Faculty of Medicine, Kyoto University, Kyoto, Japan Key words: brain neoplasm, germinoma, CNS, recurrence, radiotherapy, chemotherapy Comments This is a well written descriptive article which details the results of salvage irradiation for patients treated with primary chemotherapy for primary CNS germinoma. It appropriately references relevant articles and provides some guidelines which may prove useful to oncologists caring for patients with this unusual, though highly curable malignancy. Combined modality therapy may provide improved quality of life with no compromise of survival. What the ultimate relapse rate is for patients treated with curative intent for primary CNS germinoma is still unknown. Highly effective salvage for patients has now been shown to be possible with reasonable doses of radiotherapy by both Shibamoto et al. and Merchant et al. It would seem reasonable to assume that low-dose radiotherapy may be able to prevent CNS relapse as a post-chemotherapy adjunctive treatment, but the appropriate doses and volumes to treat in such a setting are speculative, and it would thus seem appropriate to reserve irradiation for salvaging CNS failures in patients treated with primary chemotherapy. J. Knisely (Newhaven, CT, USA) Summary Systemic chemotherapy has been increasingly used in the primary treatment of intracranial germinoma. However, the recurrence rate seems to be very high after treatment with chemotherapy alone. We used radiation to treat 5 patients harboring intracranial germinoma that recurred following primary chemotherapy. They had received systemic chemotherapy (4 with cisplatin plus etoposide and 1 with adriamycin, vincristine, cyclophosphamide, prednisolone, and cisplatin) 7 24 months before referral. All patients were treated with conventional radiotherapy directed to the primary tumor site or the craniospinal axis with a dose to the primary site ranging from 39.6 to 47.0 Gy (mean, 42.6 Gy). Response to radiation of all the recurrent tumors was good and all tumors disappeared on diagnostic imaging below the dose of 24 Gy. All patients are alive without further recurrence at months after salvage radiotherapy. Germinomas recurring after primary chemotherapy do not seem to have acquired cross resistance to radiotherapy. They can usually be cured by standard radiation therapy with Gy. Introduction Intracranial germinoma is the most radiosensitive among all primary brain tumors, and until recently it has usually been treated with conventional radiotherapy alone, with resulting overall and relapse-free survival rates at 10 years usually exceeding 90% [1 6]. Radiation doses around 50 Gy have been most frequently used to treat this tumor; 50 Gy is safe in terms of the low incidence of radiation-induced brain necrosis, but endocrine dysfunction, brain atrophy, and intellectual dysfunction may develop at this dose level. To avoid these adverse effects of radiation on normal brain tissue, chemotherapy has been introduced as a treatment for intracranial germinoma. It has been shown that this tumor responds well to systemic chemotherapy, and complete response to chemotherapy is often obtained [7,8].
2 182 Based on these observations, some groups have started clinical studies of the treatment of germinomas with chemotherapy plus reduced dose (24 40 Gy) radiotherapy [9 12], while others have used systemic chemotherapy alone [7,8]. Although the short-term results of the former studies are encouraging, longterm follow-up data are not yet available. On the other hand, it has recently become evident that the latter approach (chemotherapy alone) is associated with an unacceptably high recurrence rate [8]. Despite the high recurrence rate, a minority of investigators seem to be still pursuing the approach of chemotherapy alone. Although many patients treated with chemotherapy alone seem to be still recurrence-free at present, they may develop recurrence in the near future, and management of such patients with recurrence may become an important issue. We have encountered 5 patients with intracranial germinoma recurring after primary chemotherapy. We treated them with radiation therapy using our standard (or only slightly higher) doses [1]. This report describes the results of the treatment. Patients and methods Details of the 5 patients are shown in Table 1. At first presentation, only 1 patient underwent resection of the tumor: this patient underwent subtotal removal of a pineal tumor, while his suprasellar tumor was not resected. Magnetic resonance imaging and computed tomography findings of all the tumors were compatible with those of intracranial germinoma. Since the average diameter of all the tumors at recurrence decreased by more than 80% below the dose of Gy, our criteria for clinical diagnosis of intracranial germinoma [13] were fulfilled. Four of the 5 patients had been treated with 2 or 3 cycles of cisplatin (20 mg/m 2 5 days) and etoposide (60 mg/m 2 5 days). The other patient had received a combination chemotherapy with vincristine, cyclophosphamide, adriamycin, and prednisolone (doses unknown) together with additional cisplatin (20 mg 4). All of the tumors had disappeared following chemotherapy, but they recurred 7 24 months later. Radiation therapy was given to the 5 patients at the time of recurrence using our standard techniques [14]. No patient received surgery at recurrence. Four patients were treated with radiation therapy alone, while 1 patient (the second in Table 1) was given 2 courses of the cisplatin/etoposide chemotherapy after radiation by the attending neurosurgeon at the referring hospital. For the 2 patients with negative cerebrospinal fluid (CSF) cytology and no CSF dissemination, focal radiation was given. Major parts of the ventricular system were included in the focal radiation field. For the 3 patients with disseminated tumors, craniospinal irradiation followed by focal boost was given. The daily dose was 1.7 or 1.8 Gy for the focal irradiation (except for the first patient who received 3 fractions of 1.5 Gy in the beginning of his treatment) and 1.6 or 1.7 Gy for craniospinal irradiation. The total radiation dose was determined according to our protocol of reduceddose irradiation for intracranial germinoma (40 Gy for tumors < 2.5 cm in diameter and 45 Gy for cm tumors) [1], but the first and fourth patients were given 1 or 2 more fractions because we were not certain of the radiosensitivity of recurrent germinoma as compared to primary germinoma. The fifth patient was given 1 additional fraction, because he had a relatively low hemoglobin level (10 11 g/dl). Results The outcomes of the patients are also shown in Table 1. All tumors quickly responded to radiation. The tumors in the second, third, and fourth patients were invisible on magnetic resonance imaging or computed tomography taken at the dose of Gy. The average diameters of the tumors in the first and fifth patients were less than 20% of those before radiotherapy at the doses of 13.0 and 12.6 Gy, respectively, and the tumors disappeared on the next diagnostic imaging, taken at 23.2 and 21.5 Gy, respectively. These responses did not seem to differ from those of primary germinoma. All patients are alive with no evidence of disease at 5 10 years after irradiation for their recurrent tumors. There have been no sequelae of treatment, and they are living normal active lives. Discussion The high chemosensitivity of intracranial germinoma has become well known in recent years. In the International Central Nervous System Germ Cell Tumor Study reported by Balmaceda et al. [8], 82% of 45 germinoma patients treated with 4 cycles of carboplatin, etoposide, and bleomycin achieved complete response. However, 49% of the patients had recurrence within a
3 Table 1. Patients with intracranial germinoma recurring after primary chemotherapy Age/Sex Primary tumor Recurrent tumor Site Size CSF Surgery Chemotherapy Months Site Size CSF Radiation Follow-up (mm) cytology to relapse (mm) cytology field dose (Gy) (months) 18/M S 25 Negative None Cisplatin 80 mg 24 S 23 Negative Focal VEPA 4 15/M P 23 Positive Shunt PE 2 8 P, LV 22 Negative CSA Focal /F P 23 Unknown Shunt PE 3 7 P 11 Negative Focal /M P 38 Positive Shunt PE th V 18 Negative CSA Focal /M P, S 20 Unknown Subtotal PE 3 9 S, LV 26 Negative CSA removal for P 4th V Focal 19.8 S = suprasellar; P = pineal; CSF = cerebrospinal fluid; VEPA = vincristine, cyclophosphamide, prednisolone, adriamycin; PE = cisplatin + etoposide; LV = lateral ventricle; 4th V = fourth ventricle; CSA = cerebrospinal axis. Longest diameter of tumor. 183
4 184 median follow up period of 31 months as of the report in All of the 5 patients in our series had achieved complete response following initial chemotherapy. We do not know the exact number of patients who were treated with chemotherapy alone in the hospitals from which the patients came, but we speculate that our 5 patients reported here would represent more than half of all patients treated with chemotherapy alone in those hospitals during the same periods. Chemotherapy with agents that do not cross the blood brain barrier (BBB), such as cisplatin and etoposide, may be effective against tumor mass where the BBB is disrupted, but it should be ineffective against tumor cells in the CSF. This is supported by the fact that 3 of the 5 patients in our series had CSF dissemination at the time of recurrence. Moreover, the disrupted BBB in the tumor may be restored halfway through the chemotherapy, which should make the subsequent chemotherapy ineffective [15]. Thus, there seems to be a limit to the efficacy of chemotherapy in the treatment of intracranial germinoma. Despite the high incidence of recurrence following chemotherapy alone, currently a considerable number of patients appear to be under observation following complete response to chemotherapy. Therefore, germinomas recurring after primary chemotherapy may continue to be found in the near future. Our experience indicates that the recurrent tumors have no acquired cross resistance to radiation, and that they can be cured with conventional radiotherapy, probably with our standard doses of Gy [1]. Merchant et al. [16] also reported successful treatment of 8 germinomas recurring after primary chemotherapy, although their followup periods (median, 32 months) were much shorter than those in our patients (median, 90 months). Since recurrent germinomas seem to be easily and successfully salvaged by radiation therapy, it may be argued that chemotherapy should be used first, but if the recurrence rate exceeds 50%, such an approach does not seem to be justified. To decrease the high incidence of recurrence following chemotherapy alone, the combination of chemotherapy and reduced dose radiation is now being increasingly investigated. Small studies suggest generally favorable outcomes, but the follow-up periods are relatively short [9,11,12]. Recently, Matsutani [17] reported an interim result of a Japanese multicenter trial in which 3 courses of carboplatin and etoposide were given before focal radiation with 24 Gy. Of the 71 patients with germinoma treated with this protocol, 5 patients developed recurrence within relatively short follow-up periods (median, 25 months). Four of the 5 recurrences occurred outside the radiation field; this fact again suggested the relative ineffectiveness of the chemotherapy for CSF prophylaxis. Considering the relatively short follow-up periods, the recurrence rate may still increase, and this treatment may prove to be inferior to standard radiotherapy in future. Recently, the use of radiosurgery is also being investigated to avoid unnecessary irradiation to normal brain tissue [18]. Thus, the optimal treatment for intracranial germinoma in terms of the best control rate with the least toxicity seems to remain unknown at present. Considering the relatively low incidence of this tumor, it is expected that ongoing and future multicenter cooperative studies will provide us with information about the best treatment for this highly curable disease. Acknowledgements This study was supported in part by the Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science and Culture ( ). References 1. Shibamoto Y, Takahashi M, Abe M: Reduction of the radiation dose for intracranial germinoma: a prospective study. Br J Cancer 70: , Huh SJ, Shin KH, Kim IH, Ahn YC, Ha SW, Park CI: Radiotherapy of intracranial germinomas. Radiother Oncol 38: 19 23, Haddock MG, Schild SE, Scheithauer BW, Schomberg PJ: Radiation therapy for histologically confirmed primary central nervous system germinoma. Int J Radiat Oncol Biol Phys 38: , Hardenbergh PH, Golden J, Billet A, Scott RM, Shrieve DC, Silver B, Loeffler JS, Tarbell NJ: Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys 39: , Shirato H, Nishio M, Sawamura Y, Myohjin M, Kitahara T, Nishioka T, Mizutani Y, Abe H, Miyasaka K: Analysis of long-term treatment of intracranial germinoma. Int J Radiat Oncol Biol Phys 37: , Aoyama H, Shirato H, Kakuto Y, Inakoshi H, Nishio M, Yoshida H, Hareyama M, Yanagisawa T, Watarai J, Miyasaka K: Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother Oncol 47: , Neuwelt EA, Williams PC, Mickey BE, Frenkel EP, Henner WD: Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood brain barrier disruption. Pediatr Neurosurg 21: 16 22, 1994
5 Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL: Chemotherapy without irradiation a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. J Clin Oncol 14: , Allen JC, DaRosso RC, Donahue B, Nirenberg A: A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system. Cancer 74: , Baranzelli MC, Patte C, Bouffet E, Couanet D, Habrand JL, Portas M, Lejars O, Lutz P, Le Gall E, Kalifa C: Nonmetastatic intracranial germinoma. The experience of the French Society of Pediatric Oncology. Cancer 80: , Matsutani M, Ushio Y, Abe H, Yamashita J, Shibui S, Fujimaki T, Takakura K, Nomura K, Tanaka R, Fukui M, Yoshimoto T, Hayakawa T, Nagashima T, Kurisu K, Kayama T, The Japanese Pediatric Brain Tumor Study Group: Combined chemotherapy and radiation therapy for central nervous system germ cell tumors: preliminary results of a phase II study of the Japanese Pediatric Brain Tumor Study Group. Neurosurg Focus 5(1): Article 7, Sawamura Y, Shirato H, Ikeda J, Tada M, Ishii N, Kato T, Abe H, Fujieda K: Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 88: 66 72, Shibamoto Y, Takahashi M, Sasai K: Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int J Radiat Oncol Biol Phys 37: , Shibamoto Y, Abe M, Yamashita J, Takahashi M, Hiraoka M, Ono K, Tsutsui K: Treatment results of intracranial germinoma as a function of the irradiated volume. Int J Radiat Oncol Biol Phys 15: , Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27: , Merchant TE, Davis BJ, Sheldon JM, Leibel SA: Radiation therapy for relapsed CNS germinoma after primary chemotherapy. J Clin Oncol 16: , Matsutani M: Indication of radiation therapy for intracranial germ cell tumors. Multiinstitutional phase II study. (Abstract in Japanese) J Jpn Soc Ther Radiol Oncol 10 (Suppl 1): 98, Regine WF, Hodes JE, Patchell RA: Intracranial germinoma: treatment with radiosurgery alone a case report. J Neuro- Oncol 37: 75 77, 1998 Address for offprints: Yuta Shibamoto, Department of Oncology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto , Japan; Tel.: (+81) ; Fax: (+81) ; yuta@frontier.kyoto-u.ac.jp
Treatment and Prognosis of Patients with Intracranial Nongerminomatous Malignant Germ Cell Tumors
369 Treatment and Prognosis of Patients with Intracranial Nongerminomatous Malignant Germ Cell Tumors A Multiinstitutional Retrospective Analysis of 41 Patients Kazuhiko Ogawa, M.D. 1 Takafumi Toita, M.D.
More informationOptimal treatment strategy for intracranial germ cell tumors: a single institution analysis
J Neurosurg Pediatrics 4:000 000, 4:506 514, 2009 Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis Clinical article Ma s ay u k i Ka n a m o r i, M.D., Ph.D.,
More informationTreatment Outcome of Radiation Therapy for Intracranial Germinoma: Adaptive Radiation Field in Relation to Response to Chemotherapy
Treatment Outcome of Radiation Therapy for Intracranial Germinoma: Adaptive Radiation Field in Relation to Response to Chemotherapy JI HYEON JOO 1, JIN-HONG PARK 1, YOUNG-SHIN RA 2, HO JOON IM 3, KYUNG
More informationCarol Marquez, M.D. Department of Radiation Medicine OHSU
Carol Marquez, M.D. Department of Radiation Medicine OHSU JL is a 8 year old boy who presented with coordination problems in using his right hand (difficulty tying his shoes) in January 2011. Imaging revealed
More informationImproved Outcome of Central Nervous System Germ Cell Tumors: Implications for the Role of Risk-adapted Intensive Chemotherapy
J Korean Med Sci 2010; 25: 458-65 ISSN 1011-8934 DOI: 1346/jkms.2015.3.458 Improved Outcome of Central Nervous System Germ Cell Tumors: Implications for the Role of Risk-adapted Intensive Chemotherapy
More informationCombined treatment modality for intracranial germinomas: results of a multicentre SFOP experience
British Journal of Cancer (1999) 79(7/8), 1199 1204 1999 Cancer Research Campaign Article no. bjoc.1998.0192 Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience
More informationBACKGROUND AND OBJECTIVES:
Intracranial germ cell tumors: a singleinstitution experience Yasser Khafaga, a Amr El Weshi, a Mohamed Nazmy, a Maher Hassounah, b Esam Alshail, b Emad Moussa, c Ayman Allam, a Amani Alkofide, c Arif
More informationIntracranial germ cell tumors (GCTs) are primary malignant
clinical article J Neurosurg Pediatr 18:573 577, 2016 Human chorionic gonadotropin detection in cerebrospinal fluid of patients with a germinoma and its prognostic significance: assessment by using a highly
More informationTHE EFFECTIVE OF BRAIN CANCER AND XAY BETWEEN THEORY AND IMPLEMENTATION. Mustafa Rashid Issa
THE EFFECTIVE OF BRAIN CANCER AND XAY BETWEEN THEORY AND IMPLEMENTATION Mustafa Rashid Issa ABSTRACT: Illustrate malignant tumors that form either in the brain or in the nerves originating in the brain.
More informationA Case of Nongerminomatous Germ Cell Tumor with Fulminant Course Concomitant Leptomeningeal Metastasis
CSE REPORT rain Tumor Res Treat 2016;4(1):21-25 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.1.21 Case of Nongerminomatous Germ Cell Tumor with Fulminant Course Concomitant
More informationPredictors of long-term survival following postoperative radiochemotherapy for pathologically confirmed suprasellar germ cell tumors
430 Predictors of long-term survival following postoperative radiochemotherapy for pathologically confirmed suprasellar germ cell tumors LEI HUO 1, XIA WANG 2, PAMELA K. ALLEN 3, LONGYUN WANG 2, YUPING
More informationNEURO-ONCOLOGY. Neuro-Oncology 15(6): , doi: /neuonc/not019 Advance Access publication March 3, 2013
Neuro-Oncology 15(6):788 796, 2013. doi:10.1093/neuonc/not019 Advance Access publication March 3, 2013 NEURO-ONCOLOGY SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized
More informationProspective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors (SIOPCNSGCTII)
1 von 9 10.12.2013 09:03 A service of the U.S. National Institutes of Health Trial record 1 of 1 for: UKM08_0057 Previous Study Return to List Next Study Prospective Trial for the Diagnosis and Treatment
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cns_embryonal_tumors
More informationPineal Region Tumors. Diagnosis and Treatment Options
Pineal Region Tumors. Diagnosis and Treatment Options Progress in Neurological Surgery Vol. 23 Series Editor L. Dade Lunsford Pittsburgh, Pa. Pineal Region Tumors Diagnosis and Treatment Options Volume
More informationTreatment of primary intracranial germ cell tumors: Single center experience with 42 clinically diagnosed cases
/, Vol. 7, No. 7 Treatment of primary intracranial germ cell tumors: Single center experience with 4 clinically diagnosed cases Qun-Ying Yang,*, Cheng-Cheng Guo,*, Mei-Ling Deng, Jian Wang, Jing Wang,
More informationChemotherapy for Childhood Medulloblastoma and Primitive Neuroectodermal Tumors
Chemotherapy for Childhood and Primitive Neuroectodermal Tumors ROGER J. PACKER, a JONATHAN L. FINLAY b a Department of Neurology, Children s National Medical Center, Washington DC, USA; b Departments
More informationCase Report Tackling a Recurrent Pinealoblastoma
Case Reports in Oncological Medicine, Article ID 135435, 4 pages http://dx.doi.org/10.1155/2014/135435 Case Report Tackling a Recurrent Pinealoblastoma Siddanna Palled, 1 Sruthi Kalavagunta, 1 Jaipal Beerappa
More informationPROCARBAZINE, lomustine, and vincristine (PCV) is
RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine
More informationJ Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION
VOLUME 22 NUMBER 10 MAY 15 2004 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive
More informationSUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT
SUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT Cheng-Ta Hsieh, 1 Cheng-Fu Chang, 1 Ming-Ying Liu, 1 Li-Ping Chang, 2 Dueng-Yuan Hueng, 3 Steven D. Chang, 4 and Da-Tong Ju 1
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM GERM CELL TUMOURS CNS Site Group Germ Cell Tumours Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationCentral nervous system (CNS) germ cell tumor is. Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report
CASE REPORT J Neurosurg Spine 26:319 324, 2017 Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report *Akitake Mukasa, MD, PhD, 1 Shunsuke Yanagisawa, MD, 1 Kuniaki
More informationProtocol for management of patients with pineal region tumours v1
Protocol for management of patients with pineal region tumours v1 West Midlands Cancer Alliance Coversheet for Cancer Alliance Expert Advisory Group Agreed Documentation This sheet is to accompany all
More informationEpendymomas: Prognostic Factors and Outcome Analysis in a Retrospective Series of 33 Patients
ORIGINAL ARTICLE Brain Tumor Res Treat 2017;5(2):70-76 / pissn 2288-2405 / eissn 2288-2413 https://doi.org/10.14791/btrt.2017.5.2.70 Ependymomas: Prognostic Factors and Outcome Analysis in a Retrospective
More informationKey Words. Neoplasms Germ cell and embryonal Brain neoplasms Pediatrics
The Oncologist Pediatric Oncology Pediatric Central Nervous System Germ Cell Tumors: A Review MARIA E. ECHEVARRÍA, JASON FANGUSARO, STEWART GOLDMAN Division of Neuro-Oncology, Department of Pediatric Hematology-Oncology
More informationOsimertinib Activity in Patients With Leptomeningeal Disease From Non-Small Cell Lung Cancer: Updated Results From the BLOOM Study
Osimertinib Activity in Patients With Leptomeningeal Disease From Non-Small Cell Lung Cancer: Updated Results From the BLOOM Study Abstract 9002 Yang JC, Kim DW, Kim SW, Cho BC, Lee JS, Ye X, Yin X, Yang
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationResection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer
Turkish Journal of Cancer Vol.31/ No. 2/2001 Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer AHMET ÖZET 1, ALİ AYDIN YAVUZ 1, MURAT BEYZADEOĞLU
More informationBrain metastases: changing visions
Brain metastases: changing visions Roberto Spiegelmann, MD Baiona, 2014 Head, Stereotactic Radiosurgery Unit Dept of Neurosurgery, Chaim Sheba Medical Center Tel Hashomer, Israel The best current estimate
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationSurvival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery
ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM LOW GRADE GLIOMAS CNS Site Group Low Grade Gliomas Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING
More informationCancer Cervix with Brain Metastasis- A rare case from a Rural center of Maharashtra
Case report Cancer Cervix with Brain Metastasis- A rare case from a Rural center of Maharashtra 1 Dr Khushboo Rastogi, 2 Dr Vandana Jain, 3 Dr Darshana Kawale, 4 Dr Siddharth Nagshet, 5 Dr Gopal Pemmaraju
More informationUpdate on Pediatric Brain Tumors
Update on Pediatric Brain Tumors David I. Sandberg, M.D. Director of Pediatric Neurosurgery & Associate Professor Dr. Marnie Rose Professorship in Pediatric Neurosurgery Pre-talk Questions for Audience
More informationResults of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas
J Neurosurg (3 Suppl Pediatrics) 107:193 198, 2007 Results of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas TADAHISA SHONO,
More informationManagement of single brain metastasis: a practice guideline
PRACTICE GUIDELINE SERIES Management of single brain metastasis: a practice guideline A. Mintz MD,* J. Perry MD, K. Spithoff BHSc, A. Chambers MA, and N. Laperriere MD on behalf of the Neuro-oncology Disease
More informationSurvival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy: A Retrospective Comparative Study
Original Article Research in Oncology June 2017; Vol. 13, No. 1: 18-22. DOI: 10.21608/resoncol.2017.552.1022 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy:
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationThe role of adjuvant chemotherapy following resection of early stage thymoma
Perspective The role of adjuvant chemotherapy following resection of early stage thymoma Masatsugu Hamaji Department of Thoracic Surgery, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto,
More informationHematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma
Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Policy Number: Original Effective Date: MM.07.013 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 02/24/2012
More informationNON-SURGICAL STRATEGY FOR ADULT EPENDYMOMA
NON-SURGICAL STRATEGY FOR ADULT EPENDYMOMA Roberta Rudà Department of Neuro-Oncology University and City of Health and Science Hospital of Turin, Italy EORTC EANO ESMO Conference 2015 Istanbul, March 27-28
More informationRadiotherapy in the management of optic pathway gliomas
Turkish Journal of Cancer Vol.30/ No.1/2000 Radiotherapy in the management of optic pathway gliomas FARUK ZORLU, FERAH YILDIZ, MURAT GÜRKAYNAK, FADIL AKYOL, İ. LALE ATAHAN Department of Radiation Oncology,
More informationProspective study evaluating a strategy of surgery alone and surveillance in FIGO stage I malignant ovarian germ cell tumor (KGOG 3033)
Prospective study evaluating a strategy of surgery alone and surveillance in FIGO stage I malignant ovarian germ cell tumor (KGOG 3033) Investigators/Collaborators: Jeong-Yeol Park, M.D., Ph.D. Department
More informationSelecting the Optimal Treatment for Brain Metastases
Selecting the Optimal Treatment for Brain Metastases Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Understand the benefits, limitations,
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More informationAbscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report
Abscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report MAMIKO TAKAYA 1, YUZURU NIIBE 1, SHINPEI TSUNODA 2, TOSHIKO JOBO 2, MANAMI
More informationSee the corresponding editorial in this issue, pp J Neurosurg Pediatrics 11: , 2013 AANS, 2013
See the corresponding editorial in this issue, pp 105 106. J Neurosurg Pediatrics 11:107 114, 2013 AANS, 2013 The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions
More informationIntraoperative Radiation Therapy for
Frontiers ofradiation Therapy and Oncology Reprint Editors: J.M. Vaeth, J.L. Meyer, San Francisco, Calif. ~' Publishers: S.Karger, Basel Printed in Switzerland Vaeth JM, Meyer JL (eds): The Role of High
More informationLung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We
Lung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We Edward Garon, MD, MS Associate Professor Director- Thoracic Oncology Program David
More informationMinesh Mehta, Northwestern University. Chicago, IL
* Minesh Mehta, Northwestern University Chicago, IL Consultant: Adnexus, Bayer, Merck, Tomotherapy Stock Options: Colby, Pharmacyclics, Procertus, Stemina, Tomotherapy Board of Directors: Pharmacyclics
More informationOriginal Study. 40 Clinical Lung Cancer January 2013
Original Study Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation Patricia Tai, 1 Avi Assouline, 2 Kurian Joseph, 3 Larry Stitt, 4 Edward
More information: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate
CURRICULUM VITAE NAME Hyun Woo Lee, M.D. EDUCATION 1991.3.-2001.2 : Ajou University College of Medicine, Suwon, Korea; Doctor of Medicine 2004.3-2006.2 Ajou University College of Medicine, Graduate School,
More informationFeasibility Trial of Optune for Children with Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma
Feasibility Trial of Optune for Children with Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma ABSTRACT Recurrent or progressive pediatric CNS tumors generally have a poor prognosis
More informationJAMA. 2006;295:
ORIGINAL CONTRIBUTION Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases A Randomized Controlled Trial Hidefumi Aoyama, MD,
More informationBone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery
Bone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery Rafael Martínez-Monge 1,* Agata Pérez-Ochoa 1, Mikel San Julián 2, Dámaso Aquerreta
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationPrior to 1993, the only data available in the medical
Neuro-Oncology Prospective clinical trials of intracranial low-grade glioma in adults and children Edward G. Shaw 1 and Jeffrey H. Wisoff Department of Radiation Oncology, Wake Forest University School
More informationRadiotherapy induced intracranial growing teratoma syndrome in a pediatric germ cell tumor: a case report and literature review
Radiotherapy induced intracranial growing teratoma syndrome in a pediatric germ cell tumor: a case report and literature review Songping Zheng 1, Seidu A Richard 1,3, Yiyun Fu 2, Yan Ju 1*, Chao You 1
More informationExploring the potential for clinical introduction of hippocampal-sparing IMPT of pediatric medulloblastoma - Past present and future
Exploring the potential for clinical introduction of hippocampal-sparing IMPT of pediatric medulloblastoma - Past present and future Daniel Gasic Disclosure Nothing to disclose Introduction Background
More informationThe Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationTreatment of Recurrent Brain Metastases
Treatment of Recurrent Brain Metastases Penny K. Sneed, M.D. Dept. of Radiation Oncology University of California San Francisco Background Brain metastases occur in 8.5-15% of cancer pts in population-
More information19(12), , 2017 doi: /neuonc/nox122 Advance Access date 5 July 2017
Neuro-Oncology 19(12), 1661 1672, 2017 doi:10.1093/neuonc/nox122 Advance Access date 5 July 2017 1661 Outcome of patients with intracranial nongerminomatous germ cell tumors lessons from the SIOP-CNS-GCT-96
More informationHypofractionated radiation therapy for glioblastoma
Hypofractionated radiation therapy for glioblastoma Luis Souhami, MD, FASTRO Professor McGill University Department of Oncology, Division of Radiation Oncology Montreal Canada McGill University Health
More informationASJ. Myxopapillary Ependymoma of the Cauda Equina in a 5-Year-Old Boy. Asian Spine Journal. Introduction
Asian Spine Journal 846 Masashi Case Uehara Report et al. Asian Spine J 2014;8(6):846-851 http://dx.doi.org/10.4184/asj.2014.8.6.846 Asian Spine J 2014;8(6):846-851 Myxopapillary Ependymoma of the Cauda
More informationTreatment of Recurrent. Central Nervous System. Primitive Neuroectodermal Tumours (PNETs) in Children and Young People. Version 1.
Treatment of Recurrent Central Nervous System Primitive Neuroectodermal Tumours (PNETs) in Children and Young People Version 1.0 September 2011 Barry Pizer on behalf of the CCLG CNS Interest Group Guidance
More informationThe technique of craniospinal irradiation of paediatric patients in supine position
The technique of craniospinal irradiation of paediatric patients in supine position Pavel Šlampa 1, Zuzana Seneklova 1, Jiri Simicek 1, Renata Soumarova 1, Petr Burkon 2, Ludmila Burianova 2 1 Masaryk
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM MEDULLOBLASTOMA AND PNET CNS Site Group Medulloblastoma and PNET Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2. PREVENTION
More informationDisclosure. Paul Medin teaches radiosurgery courses sponsored by BrainLAB Many animals (and humans) were harmed to make this presentation possible!
Disclosure The tolerance of the nervous system to SBRT: dogma, data and recommendations Paul Medin, PhD Paul Medin teaches radiosurgery courses sponsored by BrainLAB Many animals (and humans) were harmed
More informationMALIGNANT GLIOMAS: TREATMENT AND CHALLENGES
MALIGNANT GLIOMAS: TREATMENT AND CHALLENGES DISCLOSURE No conflicts of interest to disclose Patricia Bruns APRN, CNS Givens Brain Tumor Center Abbott Northwestern Hospital October 12, 2018 OBJECTIVES THEN
More informationCitation Pediatrics international (2015), 57.
Title Long-term efficacy of bevacizumab a pediatric glioblastoma. Umeda, Katsutsugu; Shibata, Hirofum Author(s) Hiramatsu, Hidefumi; Arakawa, Yoshi Nishiuchi, Ritsuo; Adachi, Souichi; Ken-Ichiro Citation
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM ANAPLASTIC GLIOMAS CNS Site Group Anaplastic Gliomas Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationRadiotherapy for Brain Metastases
Radiotherapy for Brain Metastases Robert B. Den, MD a, David W. Andrews, MD b, * KEYWORDS Brain metastases Treatment approaches SRS WBRT The optimal treatment of brain metastases remains controversial.
More informationTitle Late recurrence of nonseminomatous successfully treated with intensity Author(s) Kita, Yuki; Imamura, Masaaki; Mizow Yoshiki; Yoshimura, Koji; Hiraoka, Citation Japanese journal of clinical oncolo
More informationCombining chemotherapy and radiotherapy of the chest
How to combine chemotherapy, targeted agents and radiotherapy in locally advanced NSCLC? Dirk De Ruysscher, MD, PhD Radiation Oncologist Professor of Radiation Oncology Leuven Cancer Institute Department
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress WHAT IS THE BEST PROTOCOL FOR CANINE LYMPHOMA? Antony S. Moore, M.V.Sc., Dipl. A.C.V.I.M. (Oncology) Veterinary
More informationAdditional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
Sun et al. Radiation Oncology (2018) 13:250 https://doi.org/10.1186/s13014-018-1198-4 RESEARCH Open Access Additional radiation boost to whole brain radiation therapy may improve the survival of patients
More informationSystemic Treatment. Third International Neuro-Oncology Course. 23 May 2014
Low-Grade Astrocytoma of the CNS: Systemic Treatment Third International Neuro-Oncology Course São Paulo, Brazil 23 May 2014 John de Groot, MD Associate Professor, Neuro-Oncology UT MD Anderson Cancer
More informationNe u r o s u r g i c a l intervention for the patient with a. Surgical management of primary central nervous system germ cell tumors
See the corresponding editorial in this issue, pp 123 124. J Neurosurg Pediatrics 6:000 000, 6:125 130, 2010 Surgical management of primary central nervous system germ cell tumors Proceedings from the
More informationCNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
CNS TUMORS D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS The annual incidence of intracranial tumors of the CNS ISmore than intraspinal tumors May be Primary or Secondary
More informationIntroduction. Akifumi Miyakawa 1 Yuta Shibamoto 1 Shinya Takemoto 2 Toru Serizawa 3 Shinya Otsuka 4 Tatsuo Hirai 5
DOI 10.1007/s10147-016-1058-x ORIGINAL ARTICLE Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable
More informationIntrathecal chemotherapy for refractory. for disseminated medulloblastoma. ORIGINAL PAPER
DOI 10.1007/s00381-007-0538-8 ORIGINAL PAPER Intrathecal chemotherapy for refractory disseminated medulloblastoma Junichi Yoshimura & Kenichi Nishiyama & Hiroshi Mori & Hideaki Takahashi & Yukihiko Fujii
More informationOptic Pathway Gliomas, Germinomas, Spinal Cord Tumours. Colin Kennedy March 2015
Optic Pathway Gliomas, Germinomas, Spinal Cord Tumours Colin Kennedy March 2015 Glioma of the optic chiasm. T1-weighted MRI with gadolinium enhancement, showing intense irregular uptake of contrast. The
More informationCombined treatment of Brain metastases: Radiosurgery and Targeted therapy
Combined treatment of Brain metastases: Radiosurgery and Targeted therapy Stephanie Kroeze, MD PhD OVERVIEW Introduction brain metastases Targeted therapy as monotherapy Efficacy of SRS combined with Targeted
More informationCarmustine implants and Temozolomide for the treatment of newly diagnosed high grade glioma
National Institute for Health and Clinical Excellence Health Technology Appraisal Carmustine implants and Temozolomide for the treatment of newly diagnosed high grade glioma Personal statement Conventional
More informationGamma Knife Radiosurgery A tool for treating intracranial conditions. CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop
Gamma Knife Radiosurgery A tool for treating intracranial conditions CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop ANGELA McBEAN Gamma Knife CNC State-wide Care Coordinator Gamma Knife
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM MENINGIOMA CNS Site Group Meningioma Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION 3 2. PREVENTION
More informationHematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma
Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Policy Number: Original Effective Date: MM.07.013 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 04/22/2016
More informationBrain Metastases Associated With Germ Cell Tumors May Be Treated With Chemotherapy Alone
Brain Metastases Associated With Germ Cell Tumors May Be Treated With Chemotherapy Alone Anna Hardt, MRCP 1 ; Jonathan Krell, MRCP 2 ; Peter D. Wilson, FRCP 1 ; Victoria Harding, MRCP 3 ; Simon Chowdhury,
More informationTesticular cancer and other germ cell tumours. London Cancer Jonathan Shamash
Testicular cancer and other germ cell tumours London Cancer 2018 Jonathan Shamash Background Testicular germ cell tumours are the commonest cancers of young men Overall they are curable but long term side
More informationStereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms. Overall Clinical Significance 8/3/13
Stereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms Jason Sheehan, MD, PhD Departments of Neurosurgery and Radiation Oncology University of Virginia, Charlottesville, VA USA Overall
More informationIntracranial AT RT / radiotherapy. Therapeutic dilemma / radiotherapy
Therapeutic dilemma / radiotherapy Agressive tumour, poor outcome Past treatments based on MB concepts (RT CSA) MB Overall survival Mean age : 6.52 years n=36, 5 year 75% 1. Tumour occurs in the very young
More informationLong-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure?
J Neurosurg (Suppl) 102:119 123, 2005 Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure? TATSUYA KOBAYASHI, M.D., PH.D., YOSHIMASA
More informationtrial update clinical
trial update clinical by John W. Mucenski, BS, PharmD, Director of Pharmacy Operations, UPMC Cancer Centers The treatment outcome for patients with relapsed or refractory cervical carcinoma remains dismal.
More informationUtility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer
Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department
More informationThe Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer
Evidence-based Series # 7-13-3 EDUCATION AND INFORMATION 2013 The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Members of the Lung Cancer
More informationRapidly Progressing Germinoma Arising in the Lateral Ventricle and This Mimicked Choroid Plexitis 1
Rapidly Progressing Germinoma Arising in the Lateral Ventricle and This Mimicked Choroid Plexitis 1 Jae Choon Pang, M.D., Jun Soo Byun, M.D., Jae Kyun Kim, M.D., Sam Yeol Ha, M.D. 2, Kwang Yeol Park, M.D.
More informationManagement of Single Brain Metastases Practice Guideline Report #9-1
Management of Single Brain Metastases Practice Guideline Report #9-1 A.P. Mintz, J. Perry, G. Cairncross, A. Chambers and members of the Neuro-oncology Disease Site Group Report Date: August 17, 2004 SUMMARY
More informationHematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma
Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Policy Number: 8.01.28 Last Review: 7/2014 Origination: 7/2002 Next Review: 7/2015 Policy Blue Cross and Blue Shield of Kansas
More information